Joy David
Overview
Explore the profile of Joy David including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clinical Outcomes of Early Phenotype-Desirable Antimicrobial Therapy for Enterobacterales Bacteremia
Moon R, MacVane S, David J, Morton J, Rosenthal N, Claeys K
JAMA Netw Open
. 2024 Dec;
7(12):e2451633.
PMID: 39714841
Importance: Initiating effective therapy early is associated with improved survival among patients hospitalized with gram-negative bloodstream infections; furthermore, providing early phenotype-desirable antimicrobial therapy (PDAT; defined as receipt of a β-lactam...
2.
Moon R, MacVane S, David J, Morton J, Rosenthal N, Claeys K
Antimicrob Steward Healthc Epidemiol
. 2024 Oct;
4(1):e183.
PMID: 39450100
Background: Using a large, geographically diverse, hospital-based database in the United States (Premier PINC AI Healthcare Database), we aimed to describe the proportion and characteristics of patients receiving phenotype-desirable antimicrobial...
3.
Jaishree J, Kumaresan S, Sudha S, David J, Kulkarni C
Pol J Pharmacol
. 2003 Oct;
55(4):559-64.
PMID: 14581714
Protective effects of anticovulsant agents, N6-cyclopentyladenosine (CPA) and flunarizine (FLN) against aminophylline (AMPH) (280 mg/kg)-induced convulsions were tested in different groups of mice. All drugs were administered by intraperitoneal route....
4.
Manjula D, David J, Kulkarni C
Pol J Pharmacol
. 2002 Oct;
54(3):285-91.
PMID: 12398162
This study was conducted to evaluate the prescribing pattern of anti-seizure medications (ASMs) at a tertiary care hospital. The extent and pattern of concurrently used medications for co-exiting illnesses was...